BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 27, 2006
View Archived Issues
ES-936 suppresses growth of pancreatic tumors in mice
Read More
Pierre Fabre profiles its novel atypical antipsychotic candidate
Read More
Distinct preclinical activity for PPARgamma partial agonist SVT-002149 as compared to rosiglitazone
Read More
Biogen Idec and Alnylam collaborate to develop RNAi therapeutics for PML
Read More
Protox seeks Canadian clearance for phase I study of PRX-302 for BPH
Read More
Topigen selects TPI-1100 as clinical candidate for COPD
Read More
Animal studies show PhG-alpha1 effective via intraperitoneal administration
Read More
AZ-004 studied in phase IIa trial for treatment of agitation in schizophrenic patients
Read More
Enrollment completed in phase II study of AV-608 for social anxiety disorder
Read More
Sanofi-aventis and UCB sign U.S. copromotion agreement for Xyzal
Read More
Phase I findings for Azixa warrant initiation of phase II
Read More
Merck & Co. discontinues development of MK-0354 for atherosclerosis
Read More
PharmAthene awarded Department of Defense contract for Protexia development
Read More
First clinical study for Sanofi pasteur's cell culture seasonal influenza vaccine
Read More
No statistically significant improvement by PRX-00023 on primary GAD endpoint
Read More
Recent Pfizer and Solvay patents disclose new agents for schizophrenia and depression
Read More
Therapeutic agents for respiratory disorders described in recent patents
Read More
Novel LXRbeta modulators prepared and tested at Wyeth
Read More
Gabapentin-lactam derivatives show antidepressant-like activity in vivo
Read More
NDA submission for orBec in gastrointestinal GVHD
Read More
Grazax approved in E.U.
Read More
Soliris filed in E.U. for paroxysmal nocturnal hemoglobinuria
Read More
Bayer presents further data on its new PDE11 inhibitor BAY-65-6207
Read More
Vasopressin 1A receptor antagonists presented by Azevan
Read More
Lilly reports on new beta3-adrenergic receptor agonists as potential antiobesity agents
Read More
MK-0364: Merck & Co.'s novel CB1 inverse agonist for the treatment of obesity
Read More
Midsize drug deals in Europe
Read More